RNGE Stock Overview
Provides health and wellness products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Range Impact, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.17 |
| 52 Week High | US$0.55 |
| 52 Week Low | US$0.10 |
| Beta | 2.09 |
| 11 Month Change | -31.68% |
| 3 Month Change | -36.13% |
| 1 Year Change | 21.02% |
| 33 Year Change | -37.74% |
| 5 Year Change | 115.56% |
| Change since IPO | -97.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| RNGE | US Commercial Services | US Market | |
|---|---|---|---|
| 7D | -22.1% | -1.4% | 1.0% |
| 1Y | 21.0% | 36.2% | 32.3% |
Return vs Industry: RNGE underperformed the US Commercial Services industry which returned 35.9% over the past year.
Return vs Market: RNGE underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| RNGE volatility | |
|---|---|
| RNGE Average Weekly Movement | 19.2% |
| Commercial Services Industry Average Movement | 7.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RNGE's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: RNGE's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 24 | Mike Cavanaugh | www.rangeimpact.com |
Range Impact, Inc., together with its subsidiaries, provides health and wellness products in the United States. The company operates through five segments: Range Reclaim, Range Water, Range Security, Range Land, and Drug Development. It develops VBX-100, a glycosylated tetrahydrocannabinol cannabinoid for the inflammatory conditions of the gastrointestinal tract.
Range Impact, Inc. Fundamentals Summary
| RNGE fundamental statistics | |
|---|---|
| Market cap | US$18.03m |
| Earnings (TTM) | -US$7.33m |
| Revenue (TTM) | US$15.31m |
1.2x
P/S Ratio-2.5x
P/E RatioIs RNGE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RNGE income statement (TTM) | |
|---|---|
| Revenue | US$15.31m |
| Cost of Revenue | US$13.95m |
| Gross Profit | US$1.36m |
| Other Expenses | US$8.69m |
| Earnings | -US$7.33m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.07 |
| Gross Margin | 8.88% |
| Net Profit Margin | -47.89% |
| Debt/Equity Ratio | 182.4% |
How did RNGE perform over the long term?
See historical performance and comparison